BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
Biomea Fusion, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.84−0.03 (-3.84%)
Close on Oct 19, 2026
- Market cap
- $60.46M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.6745 (−44.67%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $60.46M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.98
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$32.54M
- EPS, diluted
- -$1.18
- Book value per share
- $0.17
- Diluted shares
- 72M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$58.06M
Net income
-$32.54M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months